WUXI BIO (02269): Miao Jingwen appointed as non-executive director.
Wu Yibing, Ph.D., has resigned as of November 20, 2024, in an announcement from WuXi Biologics (02269).
WUXI BIO (02269) announces that, effective from November 20, 2024, Dr. Wu Yibing has resigned as a non-executive director and member of the Board's decision-making committee to dedicate more time to other personal matters. Ms. Miao Jingwen has been appointed as a non-executive director and member of the decision-making committee.
Related Articles
HK Stock Market Move | GDS-SW (09698) rises by over 5%, subsidiary DayOne Data Center completes $2 billion C round financing.
BYD Company Limited (01211) won the championship in the green certification consumer vehicle industry, ranking 21st overall.
HK Stock Market Move | KNOWLEDGE ATLAS (02513) surged over 24%, will launch a new generation model GLM-5. Institutions have high expectations for its core competitiveness.
HK Stock Market Move | GDS-SW (09698) rises by over 5%, subsidiary DayOne Data Center completes $2 billion C round financing.
BYD Company Limited (01211) won the championship in the green certification consumer vehicle industry, ranking 21st overall.
HK Stock Market Move | KNOWLEDGE ATLAS (02513) surged over 24%, will launch a new generation model GLM-5. Institutions have high expectations for its core competitiveness.
RECOMMEND
Bank Of America Sees Three Drivers Supporting Chinese Consumer Stocks: Low Base, Deep Undervaluation, And Convertible‑Like Defensive Traits
07/01/2026
Cross‑Border E‑Commerce In 2025: Tariffs, Trade Wars, And Shifting Away From The United States
07/01/2026
Asian Stock Markets Record The Strongest Annual Start Ever As Shanghai Composite Hits Multi‑Year High And Sets Longest Winning Streak; Japan And Korea Rally
07/01/2026
